期刊
LANCET NEUROLOGY
卷 12, 期 1, 页码 92-104出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(12)70259-4
关键词
-
资金
- Interuniversity Attraction Poles program of the Belgian Science Policy Office
- Foundation for Alzheimer's Research
- Methusalem Excellence Grant from the Flemish Government
- Research Foundation Flanders
- Special Research Fund of the University of Antwerp
In the search for new genes in Alzheimer's disease, classic linkage-based and candidate-gene-based association studies have been supplanted by exome sequencing, genome-wide sequencing (for mendelian forms of Alzheimer's disease), and genome-wide association studies (for non-mendelian forms). The identification of new susceptibility genes has opened new avenues for exploration of the underlying disease mechanisms. In addition to detecting novel risk factors in large samples, next-generation sequencing approaches can deliver novel insights with even small numbers of patients. The shift in focus towards translational studies and sequencing of individual patients places each patient's biomaterials as the central unit of genetic studies. The notional shift needed to make the patient central to genetic studies will necessitate strong collaboration and input from clinical neurologists.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据